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Abstract 41 
42 
Objective: 43 
Junctional separation and resulting type IIIa endoleak is a well-known problem after EVAR 44 
(endovascular aneurysm repair).  This complication results in sac pressurization, enlargement, and 45 
eventual rupture.  In this manuscript, we review the incidence of this late finding in our experience with 46 
the Cook Zenith Fenestrated endoprosthesis (ZFEN, Bloomington, IN) 47 
48 
Methods: 49 
A retrospective review was performed of a prospectively maintained institutional ZFEN FEVAR 50 
(fenestrated EVAR) database capturing all ZFENs implanted at a large-volume, academic hospital 51 
system.  Patients who experienced junctional separation between the fenestrated main body and distal 52 
bifurcated graft (with or without type IIIa endoleak) at any time after initial endoprosthesis implantation 53 
were subject to further evaluation of imaging and medical records to abstract clinical courses.  54 
55 
Results: 56 
In 110 ZFENs implanted from October 2012 to December 2017 followed for a mean of 1.5 years, 57 
we observed a 4.5% and 2.7% incidence of clinically significant junctional separation and type IIIa 58 
endoleak, respectively.  Junctional separation was directly related to concurrent type Ib endoleak in all 59 
five patients.  Three patients presented with sac enlargement.  One patient did not demonstrate any 60 
evidence of clinically significant endoleak and had a decreasing sac size during follow-up imaging.  The 61 
mean time to diagnosis of modular separation in these patients was 40 months.  Junctional separation was 62 
captured in surveillance in two patients and reintervened upon before manifestation of endoleak.  63 
However, the remaining three patients completed modular separation resulting in rupture and emergent 64 
intervention in two and an aortic-related mortality in the other.   65 
66 
Conclusions: 67 
Junctional separation between the fenestrated main and distal bifurcated body with the potential 68 
for type IIIa endoleak is an established complication associated with the ZFEN platform.  Therefore, we 69 
advocate for maximizing aortic overlap during the index procedure followed by aggressive surveillance 70 
and treatment of stent overlap loss captured on imaging.  71 
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Background 72 
73 
The Zenith Fenestrated aortic endoprosthesis was approved by the FDA in 2012 for short-neck 74 
infrarenal and juxtarenal aneurysms after successful demonstration of feasibility, safety, and 75 
effectiveness.1  This modular device is custom-created with main body fenestrations to allow for the 76 
stenting of one or more visceral vessels in close proximity to the aneurysmal neck, effectively extending 77 
the proximal seal zone.  As a result, the availability of this device outside of the purview of clinical trial 78 
regulations has generated a significant increase in ZFENs implanted outside manufacturer’s IFU 79 
(instructions for use).2  We have previously reported acceptable mid-term institutional results after our 80 
first one hundred implanted ZFENs.3  Not surprisingly, the implantation of this complex aortic stent graft, 81 
often for challenging anatomy relative to open and conventional endovascular repair, has been associated 82 
with a higher rate of late complications and reinterventions.4  One such feared complication after ZFEN is 83 
distal migration of the bifurcated graft resulting in component separation, sac pressurization, and 84 
catastrophic rupture.  In this secondary investigation, we report our incidence and experience with this 85 
specific complication after ZFEN.  86 
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Methods 87 
88 
This study was approved by the Indiana University Institutional Review Board (#1311843883); 89 
informed consent was not required for the proposed protocol.  A retrospective review, consistent with the 90 
principles outlined in the latest iteration of the Declaration of Helsinki, of a prospectively maintained 91 
ZFEN database was performed to isolate all junctional separation events diagnosed in patients treated 92 
with FEVAR from 2012 to 2017.5  Suspected type III endoleaks arising because of fabric tears or via the 93 
junction of the visceral covered stents and the main body fenestrations were excluded leaving only 94 
component separations of the proximal and distal aortic pieces.   95 
96 
The preoperative and intraoperative decision making for ZFEN implantation at our institution has 97 
been described in detail elsewhere.6  Among the IFU for the ZFEN device includes a minimal proximal 98 
neck length of 4 mm, proximal neck diameter of 19 – 31 mm, and proximal neck angulation of <45°.  99 
Maximum overlap is encouraged whenever possible between the aortic components with a minimum 100 
overlap of 2 stent increments or 36 mm (Figure 1).  Postoperative surveillance after ZFEN at our 101 
institution consists of a serum creatinine and CT angiography (CTA) at one-month, six-months, and 12-102 
months followed by annual scans thereafter.  If evidence of endoleak or sac expansion were noted, 103 
intervals between scans were shortened at the discretion of the attending vascular surgeon.  For patients 104 
with renal insufficiency, we performed surveillance imaging at the same intervals with the substitution of 105 
a noncontrasted CT and a mesenteric/renal/aortic duplex sonogram for the CTA. 106 
107 
Three-dimensional aortic reconstruction for all postoperative scans were performed in Aquarius 108 
Workstation (TeraRecon, Foster City, CA).  Centerline measurements were obtained to generate 109 
junctional overlap changes over time for each individual.  For measurement purposes, junctional overlap 110 
was defined as the distance from the distal, metallic edge of the proximal main body to the proximal, 111 
metallic edge of the distal bifurcated graft.   112 
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Results 113 
 114 
 From October 2012 to December of 2017, a total of 110 Zenith Fenestrated aortic stent grafts 115 
were implanted for short-neck infrarenal and juxtarenal aneurysms at our institution.  The mean follow-up 116 
for this cohort was 1.5 ± 1.5 years.  We observed five cases of component separation which were 117 
intervened upon at a mean time of 40 months after the index endoprosthesis implantation (Table 1). 118 
 119 
Patient One 120 
 A 63M with a 64 mm juxtarenal AAA was repaired in April 2013 using a 32 x 124 mm proximal 121 
main body with bilateral renal artery fenestrations and a SMA (superior mesenteric artery) scallop.  The 122 
distal bifurcated graft was in a 20 x 45 x 76 mm configuration.  No endoleaks were noted at the first 123 
postoperative visit and junctional overlap at that time was 55 mm.  Aortic anatomy remained stable until 124 
18-months postprocedure, when a noncontrasted CT demonstrated residual sac enlargement to 69 mm.  125 
However, an aortic duplex did not show any evidence of endoleak.  Two years after the index operation, 126 
repeat CTA was concerning for continued sac expansion to 74 mm with a decrease in modular overlap to 127 
50 mm.  An aortic duplex was repeated which did not demonstrate any flow to the residual sac.  After 128 
discussion of more aggressive diagnostic options with the patient, he opted to continue noninvasive 129 
imaging and defer a diagnostic angiogram.  At his 3-year postoperative visit, his residual sac was stable 130 
without endoleak evidence.  Unfortunately, continued decrease in junctional overlap to 37 mm secondary 131 
to progressive angulation of the distal sac was unrecognized.  The decision at that point was to continue 132 
follow-up surveillance without intervention. 133 
 134 
 Forty-five months after the index repair, the patient presented to an outlying hospital with sudden, 135 
severe abdominal pain in the setting of profound hypotension.  A CTA demonstrated increased sac size to 136 
93 mm with evidence of retroperitoneal hematoma and acute rupture (Figure 2).  It was apparent that the 137 
right iliac limb had retracted secondary to continued distal aneurysmal degeneration, creating a large type 138 
Ib endoleak resulting in sac pressurization and progressive migration of the distal bifurcated graft.  The 139 
patient quickly became unresponsive despite initiation of massive transfusion protocols.  Eventually, the 140 
family decided to initiate comfort measures and withdraw heroic measures. 141 
 142 
Patient Two 143 
 A 78M presented to us with a 70 mm juxtarenal AAA was repaired with a 34 x 107 mm ZFEN 144 
main body with bilateral renal artery small fenestrations and a large fenestration for the SMA in 145 
December 2013.  The distal bifurcated graft was in a 24 x 62 x 76 mm configuration with the iliacs sealed 146 
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via 20 mm limb extensions.  At his initial postoperative visit, a type II lumbar artery endoleak was visible 147 
with an initial junctional overlap of 50 mm.  Twelve months after his index operation, follow-up CTA, 148 
once again, demonstrated the continued presence of the type II endoleak, sac expansion to 76 mm, and a 149 
decrease in junctional overlap to 38 mm.  As a result, we performed an angiogram where it was noted that 150 
the residual sac was being fed from an iliolumbar branch off the hypogastric artery; an adequate 151 
angiographic result was noted after targeted coil embolization of this hypertrophied collateral. 152 
153 
At his 24-month follow-up, a CTA demonstrated continued sac expansion to 80 mm without a 154 
clear source of endoleak; junctional overlap was now 30 mm.  At this point, we suspected a type Ib 155 
endoleak was continuing to pressurize the sac.  Therefore, we took the patient to the operating theatre 156 
where a provoked angiogram confirmed the suspected Ib endoleak.  We extended the distal graft with a 157 
Cook 11 x 107 mm iliac limb after embolization of the hypogastric artery.  Additionally, we placed a 40 x 158 
100 mm Palmaz stent at the modular junction and reinforced it with Aptus endoanchors (Medtronic, 159 
Minneapolis, MN). 160 
161 
Unfortunately, 34-months postprocedure, surveillance CTA once again was concerning for sac 162 
enlargement to 90 mm in the setting of large type II endoleak.  Angiogram demonstrated another 163 
hypertrophied iliolumbar vessel off the previously intervened side pressuring the residual sac.  Therefore, 164 
translumbar coil embolization was successfully performed (Figure 3).  We are currently continuing close 165 
follow-up on this patient to determine the effects of our latest reintervention.      166 
167 
Patient Three 168 
A 77M with an 80 mm juxtarenal AAA was treated in December 2014 with a 36 x 122 mm ZFEN 169 
proximal body containing bilateral renal artery small fenestrations and a SMA scallop.  The distal 170 
bifurcated graft was in a 12 x 28 x 76 mm configuration and sealed distally with bilateral 24 mm iliac 171 
limb extensions.  The first postoperative CTA did not demonstrate any evidence of endoleak with an 172 
established junctional overlap of 40 mm.  One year later, the patient presented to an OSH with new onset 173 
abdominal pain.  CTA demonstrated an enlarging sac secondary to a new type Ib endoleak which was 174 
quickly repaired using 26 mm and 28 mm x 39 mm Cook aortic cuffs.  Unfortunately, repeat imaging 20 175 
months after the index repair again demonstrated increased sac size in the presence of a large lumbar type 176 
II endoleak which had not affected the junctional structure.  The patient was taken to the OR for a 177 
successful transcaval embolization.  Unfortunately, he failed to present for follow-up after this procedure.  178 
179 
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In October 2017, 34 months after his index ZFEN, the patient, once again, presented to an OSH 180 
with abdominal pain.  Repeat CTA demonstrated complete junctional separation and a type IIIa endoleak 181 
associated with aneurysm rupture.  It appeared as if a recurrence of the type Ib endoleak caused distal 182 
migration of the bifurcated graft.  The patient was immediately taken to the operative theatre where a 28 183 
mm Gore (Flagstaff, AZ) aortic cuff was placed across the junction between proximal fenestrated and 184 
distal bifurcated bodies.  The hypogastric was embolized and a Gore 16 x 100 mm iliac limb was 185 
deployed to fix the type Ib endoleak.  The patient was eventually discharged to subacute rehabilitation 186 
where he recently completed a three-month rehabilitation stint.      187 
188 
Patient Four 189 
A 69M with a 70 mm juxtarenal AAA was repaired in July 2015 with bilateral renal fenestrations 190 
in a 32 x 107 mm ZFEN proximal body.  The distal bifurcated graft was created in a 12 x 28 x 76 mm 191 
configuration with a 24 x 74 mm left iliac limb and a right iliac extension using a 11 x 107 mm limb.  His 192 
one-month postoperative visit was unremarkable without any evidence of endoleak.  The initial junctional 193 
overlap was 35 mm.  During this time period, he was diagnosed with lymphoma and began oncologic 194 
treatment.  At eight-months postprocedure, a surveillance CTA performed for the oncologic team 195 
continued to lack evidence of endoleak in the setting of a stable residual sac; however, the junctional 196 
overlap had decreased to 26 mm secondary to increased distal angulation.  The decision at this point was 197 
to hold intervention and observe how stent morphology changed at the next clinical visit.   198 
199 
In March of 2017, routine surveillance imaging for his lymphoma was concerning for a new type 200 
Ib endoleak without evidence of sac expansion.  Additionally, a significant loss of junctional overlap to 201 
14 mm was discovered upon closer inspection.  Therefore, he was taken to the operating room for a 202 
hypogastric embolization, Cook iliac limb extension (11 x 107 mm), and placement of a Cook thoracic 203 
aortic cuff (28 x 80 mm) to bridge the modular aortic junction.  Imaging in November of 2017 204 
demonstrated both stable residual sac and aortic graft integrity without evidence of endoleak. 205 
206 
Patient Five 207 
A 65M with schizophrenia presented with an 80 mm juxtarenal AAA.  He was treated using a 28 208 
x 124 mm proximal main body with bilateral renal artery small fenestrations and a SMA scallop in 209 
February 2013.  A 12 x 28 x 121 mm distal bifurcated graft was implanted and extended with 24 x 74 mm 210 
iliac limb on the right a 12 x 122 mm on the left after successful preoperative left hypogastric 211 
embolization two weeks previously.  Modular overlap after the initial procedure was 55 mm.  Six months 212 
later, he developed a type Ib endoleak and a decrease in junctional overlap to 50 mm which was fixed 213 
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with a Cook iliac limb extension (13 x 107 mm).  The aneurysm size continued to remain stable while 214 
junctional overlap decreased to 46 mm in December 2014.  He was lost to follow-up after February of 215 
2016, where it was noted that his aneurysm size remained stable in the setting of continued junctional 216 
overlap decrease to 37 mm.   217 
218 
After failing to present to multiple follow-up appointments, the patient presented to an OSH with 219 
new abdominal pain and hypotension in January 2018.  A CTA at that time was concerning for a 220 
complete loss of junctional overlap in the setting of increasing distal aortic angulation (Figure 4).  His 221 
infrarenal aortic segment was emergently relined using a Cook thoracic graft (28 x 109 mm).  Fortunately, 222 
the patient ultimately survived to be discharged home.      223 
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Discussion 224 
225 
Using the ZFEN system, up to three modifications (no more than two of the same) in the main 226 
body consisting of a combination of fenestrations and scallops can be created to fit the visceral anatomy 227 
of the target patient.4  In the U.S., all main bodies, regardless of proximal diameter, tapers distally to 24 228 
mm where the overlap with the bifurcated piece occurs.  Similarly, the only available size for the 229 
proximal diameter of the distal bifurcated piece is in a 24 mm configuration.  As such, the only way to 230 
minimize the risk of separation is to maximize stent overlap in any given anatomy.  This limitation was 231 
artificially created secondary to the guidelines imposed by the FDA after initial ZFEN approval as the 232 
clinical trials uniformly used this conformation.  In contrast, European use of the ZFEN device is not 233 
subject to such strict regulations, and a smaller distal diameter (22 mm) of the proximal main body allows 234 
for a “friction fit” via distal upsizing with the 24 mm bifurcated piece.   235 
236 
With the introduction of modular EVAR, separation events were quickly recognized as a feared 237 
late complication which often results in rupture.  For example, Skibba et al reviewed their experience 238 
with over 700 Endologix Powerlink (Irvine, CA) grafts implanted from 2006 to 2015.  They observed a 239 
2.4% long-term incidence of type IIIa endoleak which is comparable to other smaller reports over various 240 
EVAR platforms.7,8  However, the incidence of those experiencing modular migration without endoleak 241 
remained unclear.9  Additionally, the true incidence of clinically significant type IIIa endoleaks may be 242 
much higher.  In 2016, our group published a 7.2% modular separation event rate associated with 243 
implantation of the AFX aortic graft which led to the voluntary withdrawal of a portion of available grafts 244 
by Endologix.10  Interestingly, the FDA recently distributed a warning letter to interventionalists 245 
concerning the risk of type III endoleaks after EVAR while reinforcing the need for lifelong, aggressive 246 
surveillance after the index intervention.11    247 
248 
With progressive separation, junctional leaking causes pressurization of the aneurysmal sac, alters 249 
aortic morphology, and increases the risk for rupture.  Additionally, increasingly turbulent flow dynamics 250 
exposures the patient to the risk of aortic thrombosis and acute limb ischemia.10  It is possible that the risk 251 
of junctional separation may be increased in FEVAR compared to EVAR because of the inherent fixation 252 
of the fenestrated main body to the juxtarenal aorta allowing for only the migration of the distal pieces as 253 
sac morphology changes.  Therefore, endoleaks which may have resulted in sac expansion, proximal stent 254 
migration, and type Ia endoleak in a patient with EVAR now presents with migration of the most 255 
proximal, unfixed stent.  It is important to emphasize that all patients in this series had an endoleak which 256 
preceded their separation events.  Two of these patients demonstrated isolated type II endoleaks which 257 
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resulted in eventual development of type Ib endoleaks.  Therefore, the cavalier attitude towards “clinically 258 
insignificant” endoleaks should be abandoned with respect to ZFEN as postoperative endoleak rate are 259 
increased compared to EVAR.  In our previously reported institutional experience, we found a 15% rate 260 
of identifiable endoleak by the last available CTA and a 31% incidence of endoleak at any point after 261 
graft implantation.  Of these patients, 11 of 100 underwent reintervention for persistent endoleak.3 262 
263 
The problem with ZFEN migration has been examined before in a European case series.  England 264 
et al performed a retrospective review of over 150 patients treated in the United Kingdom with a ZFEN 265 
device from 2003 and 2010.  The authors reported a proximal main body migration incidence of 21% with 266 
a probability of being free from main body migration of 82%, 77%, and 77% at 12, 24, and 36 months, 267 
respectively.  However, these migrations were generally clinically insignificant.  Similarly, they noted a 268 
13% iliac limb migration and a probability of being free from iliac limb migration at 85%, 82%, and 65% 269 
at 12, 24, and 36 months, respectively.  The authors also reported a rate of component separation, as 270 
defined as a >4 mm migration between the main body and bifurcated graft, of 11.8%.12  Unfortunately, it 271 
was unclear what proportion of the component migration events were clinically significant.   272 
273 
In this manuscript, we report five cases of clinically significant component separation between 274 
the ZFEN main body and the bifurcated distal graft over the first 110 patients treated.  Three experienced 275 
ruptures while the remaining patients were appropriately reintervened on before a catastrophic event 276 
occurred.  All were treated outside the ZFEN IFU.  Four of these patients required a 24 mm iliac limb, the 277 
maximum available size, at their index operations while the remaining patient received a 20 mm limb.  278 
Previously, Schanzer et al reported that presence of endoleak, age ≥80 years, aortic neck diameter ≥28 279 
mm, aortic neck angle ≥60°, and common iliac artery diameter ≥20 mm all independently predicted sac 280 
expansion after EVAR.13  Certainly, our patients in this series all carry more than one of these predictors.   281 
282 
We observed a failure of the iliac limb seal zone which resulted in persistent type Ib endoleaks in 283 
all five patients.  Large iliac diameters and type Ib endoleak should be taken in context of large residual 284 
sacs where lateral vector forces on components can increase distraction forces and thereby be at higher 285 
risk for type IIIa endoleak; Lemmon et al reported an OR >10 for this event to occur in the setting of a 286 
AAA >6.5 cm.10  When these initial ZFEN cases were performed, no options of iliac branch 287 
endoprosthesis were available for challenging iliac anatomy.  However, we have deployed, in several 288 
cases, iliac branch devices in combination with ZFEN to preserve at least one hypogastric artery and 289 
minimize the risk of distal leaks from aneurysmal iliac arteries.  Additionally, we are also moving back 290 
towards plain anterior-posterior and lateral abdominal X-rays before clinic visits to optimally quantify 291 
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junctional overlap, a practice we employed with first-generation EVAR devices but lost favor as more 292 
reliable aortic platforms were introduced. 293 
294 
Our series has several limitations.  The small population size makes generalization of this 295 
relatively rare complication more difficult.  Additionally, we are missing follow-up imaging studies on 296 
several patients that were lost to follow-up or decided to establish care with other vascular surgeons closer 297 
to their homes.  Therefore, it is more than probable that several graft migration events or complications 298 
were not captured by our medical system and records. 299 
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Conclusion 300 
301 
While the Zenith Fenestrated system has allowed clinicians to treat a wider range of aneurysmal 302 
pathologies, the need for careful surveillance with a high index of suspicion for junctional separation 303 
needs to be emphasized to prevent catastrophic rupture events.  304 
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Legends 
Figure 1 
The Cook Zenith Fenestrated graft is composed of a proximal main body (a) and a distal bifurcated piece 
(b).  Main body proximal diameter ranges from 24 – 36 mm and house up to three modifications 
consisting of fenestrations or scallops.  The available length of the distal main body is dependent on the 
proximal diameter.  Regardless, the junctional diameter between the proximal and distal pieces are set at a 
diameter of 24 mm, respectively.  The maximum available overlap between the two stents should be 
pursued for the individual patient. 
Figure 2 
A three-dimensional reconstruction was performed (a) demonstrating the loss of junctional apposition 
between the proximal and distal aortic pieces resulting in a type III endoleak (arrowhead).  In (b) and (c), 
coronal and sagittal views demonstrate the same anatomy.  
Figure 3 
An iliolumbar collateral (a, arrow) was feeding the residual sac causing pressurization and sac expansion. 
A right iliac limb was implanted to treat a type Ib endoleak (b).  After continued sac expansion, another 
hypertrophied iliolumbar was embolized (c). 
Figure 4 
Increasing aortic angulation in the setting of a type Ib endoleak resulted in complete junctional separation 
(arrows) between the proximal main body and distal bifurcated stent (a, b).  
Table 1 
ZFEN characteristics associated with the individual patients. 
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Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Proximal 
Diameter
32 mm 32 mm 36 mm 32 mm 28 mm
Iliac Diameter 20 mm 24 mm 24 mm 24 mm 24 mm
Initial 
Angulation 
>45°
Yes Yes No Yes Yes
Initial 
Junctional 
Overlap
55 mm 50 mm 40 mm 35 mm 55 mm
1-Year 
Overlap
53 mm 38 mm 40 mm 26 mm 50 mm
2-Year 
Overlap
50 mm 30 mm 40 mm 14 mm 46 mm
3-Year 
Overlap
37 mm 30 mm IIIa Endoleak N/A 37 mm
4-Year 
Overlap
IIIa Endoleak N/A N/A N/A IIIa Endoleak
Time to Type 
Ib Endoleak
45 months 24 months 34 months 20 months 6 months
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24 mm
24 - 36 mm
24 mm
12 - 24 mm
36 mm
Minimum Overlap 54 mm
Preferred Overlap
A B
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A B
C
Proximal
Proximal
Distal
Distal
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